Bernstein lifted its Guardant Health price target to $200 after UnitedHealth's Shield coverage decision. Here's what it means ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received ...
New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender ...
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and ...
Toronto cancer survivor says Ontario’s lowering of colon cancer screening is ‘going to change lives’
Ontario has lowered the eligibility age for colon cancer screening from 50 to 45, a move that cancer survivor Ashley Wiley ...
India launches a single blood test screening for 10 cancers, improving early detection while complementing - not replacing - ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...
Kennedy Jr.’s about to remake another government panel with power over Americans’ access to health care. This time around, ...
New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are ...
Persistent disparities in preventive cancer care exist among sexual orientation and gender identity minority individuals in the United States, according to results of a cross-sectional analysis.The ...
In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results